Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/49306| Title: | Bardoxolone Methyl for Alport Syndrome: Opportunities and Challenges. | Authors: | Quinlan C.;Jayasinghe K. | Monash Health Department(s): | Nephrology | Institution: | (Quinlan) Department of Nephrology, Royal Children's Hospital, Melbourne, Australia (Quinlan, Jayasinghe) Kidney Regeneration, Murdoch Children's Research Institute, Melbourne, Australia (Quinlan) Department of Paediatrics, University of Melbourne, Melbourne, Australia (Quinlan, Jayasinghe) Melbourne Genomics Health Alliance, Melbourne, Australia (Jayasinghe) Department of Nephrology, Monash Health, Melbourne, Australia (Jayasinghe) Department of Medicine, Monash University, Melbourne, Australia |
Issue Date: | 12-Dec-2022 | Copyright year: | 2022 | Publisher: | American Society of Nephrology | Place of publication: | United States | Publication information: | Clinical Journal of the American Society of Nephrology. 17(12) (pp 1713-1715), 2022. Date of Publication: December 2022. | Journal: | Clinical Journal of the American Society of Nephrology | DOI: | http://monash.idm.oclc.org/login?url=https://dx.doi.org/10.2215/CJN.12491022 | PubMed URL: | 36411059 [https://www.ncbi.nlm.nih.gov/pubmed/?term=36411059] | URI: | https://repository.monashhealth.org/monashhealthjspui/handle/1/49306 | Type: | Editorial | Subjects: | Alport syndrome bardoxolone methyl |
Type of Clinical Study or Trial: | Opinion, perspective or news |
| Appears in Collections: | Articles |
Show full item record
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.